[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369498-105":59,"doc-detail-369498-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","alternative-splicing-of-fbln2-generates-a-prometastatic-extracellular-matrix-in-gastrointestinal-cancers-determining-n-glycosylation-of-fibulin-2","Alternative Splicing of FBLN2 Generates a Prometastatic Extracellular Matrix in Gastrointestinal Cancers - Determining N-Glycosylation of Fibulin 2","","Fibulin 2 (FBLN2) is a glycoprotein of the extracellular matrix, and exon 9 exclusion is a frequently observed splicing event across multiple cancers. The study shows that skipping FBLN2 exon 9 removes a single N-glycosylation site, causing FBLN2 misfolding and lowering both protein stability and secretion efficiency. Consistently, human colorectal cancer tissues exhibit reduced FBLN2 abundance, while fibronectin 1 increases in the tumor microenvironment. Together, this imbalance enhances adhesion and migration of colorectal cancer cells, indicating that FBLN2 exon 9 alternative splicing creates a prometastatic extracellular environment via glycosylation-dependent control of FBLN2.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/alternative-splicing-of-fbln2-generates-a-prometastatic-extracellular-matrix-in-gastrointestinal-cancers-determining-n-glycosylation-of-fibulin-2/369498/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/alternative-splicing-of-fbln2-generates-a-prometastatic-extracellular-matrix-in-gastrointestinal-cancers-determining-n-glycosylation-of-fibulin-2/369498.png","ImageObject",300,407,{"name":92,"@type":93},"Alex Sinclair","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What recurrent splicing change in FBLN2 is highlighted in the study?","Question",{"text":113,"@type":114},"The study focuses on exclusion of exon 9 of FBLN2, which occurs frequently across multiple cancer types.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does skipping FBLN2 exon 9 affect the FBLN2 protein?",{"text":118,"@type":114},"It causes loss of an N-glycosylation site, leading to FBLN2 misfolding and reduced stability and secretion efficiency.",{"name":120,"@type":111,"acceptedAnswer":121},"What tumor microenvironment changes are associated with reduced FBLN2 in colorectal cancer?",{"text":122,"@type":114},"Reduced FBLN2 abundance accompanies increased fibronectin 1, which promotes adhesion and migration of colorectal cancer cells.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},369498,1790229951,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1099523882182,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Genes to Cells  \nORIGINAL ARTICLE  OPEN ACCESS   \nAlternative Splicing ofFBLN2 Generates a Prometastatic Extracellular Matrix in Gastrointestinal Cancers by Determining N-Glycosylation ofFibulin 2  \nRyo Funayama1,2 | Yujue Wang1,3 | Masaki Hosogane1 | Wei-Chen Kao1 | Shingo Toyama4 | Masahiro Ohira1 | Masaki Matsumoto5  | Takashi Aizawa4 | Minoru Kobayashi4 | Hideaki Karasawa4 | Shinobu Ohnuma4 | Keiichi I. Nakayama2,6  | Michiaki Unno4 | Keiko Nakayama1,7   \n1Department of Cell Proliferation, ART, Graduate School of Medicine, Tohoku University, Sendai, Japan | 2Anticancer Strategies Laboratory, Advanced Research Initiative, Institute of Science Tokyo, Tokyo, Japan | 3Department of Cellular Function, Graduate School of Life Sciences, Tohoku University, Sendai, Japan | 4Department of Surgery, Graduate School of Medicine, Tohoku University, Sendai, Japan | 5Department of Omics and Systems Biology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan | 6Department of Molecular and Cellular Biology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan | 7Research Infrastructure Management Center, Institute of Science Tokyo, Tokyo, Japan  \nCorrespondence: Keiko Nakayama ([nakayama.keiko@tmd.ac.jp](nakayama.keiko@tmd.ac.jp)) | Ryo Funayama ([funayama.ryo@tmd.ac.jp](funayama.ryo@tmd.ac.jp))  \nReceived: 11 March 2025 | Revised: 19 April 2025 | Accepted: 13 May 2025  \nTransmitting Editor: Hidenori Ichijo  \nFunding: This study was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI grants JP20K07560, JP23K06626, and JP25K10462 (to R. F.) as well as JP17H04035, JP18H05215, JP21H02458, and JP24K02300 (to K.N.) .  \nKeywords: alternative splicing | extracellular matrix | fibulin 2 | gastrointestinal cancers | glycosylation  \nABSTRACT  \nFibulin 2 (FBLN2) is an extracellular matrix glycoprotein. Exclusion of exon 9 of FBLN2 is one of the most recurrent splicing events across multiple types of cancer, but its functional relevance in cancer has remained unexplored. We here reveal that the exclusion of exon 9 ofFBLN2 results in the loss of a single N-glycosylation site that leads to misfolding of the FBLN2 protein as well as to a reduction in both its stability and secretion efficiency. Indeed, the extracellular matrix of human colorectal cancer tissue exhibits a reduced abundance ofFBLN2. This deficiency ofFBLN2 together with a concomitant increase in the abundance of fibronectin 1 in the tumor microenvironment promotes the adhesion and migration of colorectal cancer cells. Our data thus suggest that the alternative splicing of FBLN2 exon 9 generates a prometastatic extracellular environment in cancer tissue by determining FBLN2 glycosylation.  \n1 | Introduction  \nExtracellular matrix (ECM) consisting of noncellular components of the tumor microenvironment (TME) accounts for up to 60% of tumor mass (Henke et al. 2019; Anderson and Simon 2020) . This ECM is composed of various fibrous proteins including fibrillar collagens, fibronectin 1 (FN1), and fibulin  \n2 (FBLN2) (Brassart-Pasco et al. 2020; Cox 2021) . Although many cell types contribute to the production of ECM proteins in tumor tissue, fibroblasts are the major source for ECM deposition (DeLeon-Pennell et al. 2020; Winkler et al. 2020; Belhabib et al. 2021) . The meshwork architecture of ECM provides a scaffold for tumor cells to proliferate, migrate, and escape immune surveillance (Pickup et al. 2014; Kai et al. 2019) . Given that the  \n\n| Ryo Funayama, Yujue Wang, and Masaki Hosogane contributed equally to this work. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.\u003Cbr>© 2025 The Author(s). Genes to Cells published by Molecular Biology Society of Japan and John Wiley & Sons Austra","cbCairoCYiQJufwr","https://ap.wps.com/l/cbCairoCYiQJufwr","pdf",3204149,15,"English","# Introduction\n## Extracellular matrix and tumor microenvironment\n## Alternative splicing of extracellular matrix genes\n## FBLN2 as an extracellular matrix glycoprotein","[{\"question\":\"What recurrent splicing change in FBLN2 is highlighted in the study?\",\"answer\":\"The study focuses on exclusion of exon 9 of FBLN2, which occurs frequently across multiple cancer types.\"},{\"question\":\"How does skipping FBLN2 exon 9 affect the FBLN2 protein?\",\"answer\":\"It causes loss of an N-glycosylation site, leading to FBLN2 misfolding and reduced stability and secretion efficiency.\"},{\"question\":\"What tumor microenvironment changes are associated with reduced FBLN2 in colorectal cancer?\",\"answer\":\"Reduced FBLN2 abundance accompanies increased fibronectin 1, which promotes adhesion and migration of colorectal cancer cells.\"}]","Alternative Splicing of FBLN2 Generates a Prometastatic Extracellular Matrix in Gastrointestinal Cancers - Determining N-Glycosylation of Fibulin 2 | PDF",1790183089,38,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/08fb9fb4217900a346029268eb828dfd.webp",983,1291,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/871d3708ddaab6afa3d7710747b2cdbd.webp",982,1290,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aae680ccfa033695bc8c304861a7ccad.webp",981,1289,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/80a837c2bb87eaa9dc26db2c2682782a.webp",980,1287]